1. Home
  2. MBIO vs KRKR Comparison

MBIO vs KRKR Comparison

Compare MBIO & KRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • KRKR
  • Stock Information
  • Founded
  • MBIO 2015
  • KRKR 2010
  • Country
  • MBIO United States
  • KRKR China
  • Employees
  • MBIO N/A
  • KRKR N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • KRKR Business Services
  • Sector
  • MBIO Health Care
  • KRKR Consumer Discretionary
  • Exchange
  • MBIO Nasdaq
  • KRKR Nasdaq
  • Market Cap
  • MBIO 7.3M
  • KRKR 10.4M
  • IPO Year
  • MBIO N/A
  • KRKR 2019
  • Fundamental
  • Price
  • MBIO $2.82
  • KRKR $3.60
  • Analyst Decision
  • MBIO Strong Buy
  • KRKR
  • Analyst Count
  • MBIO 1
  • KRKR 0
  • Target Price
  • MBIO $100.00
  • KRKR N/A
  • AVG Volume (30 Days)
  • MBIO 403.2K
  • KRKR 1.3M
  • Earning Date
  • MBIO 03-10-2025
  • KRKR 09-03-2024
  • Dividend Yield
  • MBIO N/A
  • KRKR N/A
  • EPS Growth
  • MBIO N/A
  • KRKR N/A
  • EPS
  • MBIO N/A
  • KRKR N/A
  • Revenue
  • MBIO N/A
  • KRKR $41,654,350.00
  • Revenue This Year
  • MBIO N/A
  • KRKR $45.99
  • Revenue Next Year
  • MBIO N/A
  • KRKR $31.46
  • P/E Ratio
  • MBIO N/A
  • KRKR N/A
  • Revenue Growth
  • MBIO N/A
  • KRKR N/A
  • 52 Week Low
  • MBIO $2.40
  • KRKR $2.76
  • 52 Week High
  • MBIO $74.50
  • KRKR $12.99
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 30.01
  • KRKR 42.46
  • Support Level
  • MBIO $2.40
  • KRKR $4.20
  • Resistance Level
  • MBIO $3.04
  • KRKR $6.20
  • Average True Range (ATR)
  • MBIO 0.48
  • KRKR 1.80
  • MACD
  • MBIO 0.10
  • KRKR -0.23
  • Stochastic Oscillator
  • MBIO 15.00
  • KRKR 3.10

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About KRKR 36Kr Holdings Inc.

36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.

Share on Social Networks: